Swep Bio, Inc.

SEC filing

Biotechnology · Scarsdale, NY

Form D on EDGAR

Amount raised$2.5Msold at filing

Total offering$5M$2.5M still open

Investors in the raise1count reported to the SEC

FiledOct 29, 2026first sale Oct 28, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Goran Mikael DolstenExecutive Officer, Director

Karl Erik Emanuel BerglundExecutive Officer, Director

Lovisa BackemarDirector

Executive officers, directors and promoters as listed on the Form D.